This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Shanghaitech University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Zhihu Qu - Innovator in Antibody Research
Introduction
Zhihu Qu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work focuses on innovative solutions for medical challenges, showcasing his expertise and dedication to advancing healthcare.
Latest Patents
Zhihu Qu holds a patent for a "Fully human antibody specifically inhibiting Connexin 26." This invention provides a fully human antibody characterized as a recombinant immunoglobulin with the structure of scFv-Fc. The antibody specifically targets Connexin 26, utilizing the first 41-56 amino acid sequence of its extracellular region as an antigen. Through biochemical analysis and immunofluorescence identification, it has been confirmed that this antibody can specifically recognize Connexin 26 and inhibit its hemichannel activity. Animal experiments have demonstrated that this antibody significantly inhibits the hemichannel activity of mouse cochlear tissue sections, indicating its potential for treating Connexin mutation-associated diseases.
Career Highlights
Zhihu Qu is affiliated with ShanghaiTech University, where he conducts his research and development activities. His work has garnered attention for its innovative approach to addressing complex medical issues. With a focus on antibody development, he continues to contribute to the scientific community through his research and inventions.
Collaborations
Zhihu Qu collaborates with notable colleagues, including Guang Yang and Fabio Mammano. Their combined expertise enhances the research efforts and fosters a collaborative environment for innovation.
Conclusion
Zhihu Qu is a distinguished inventor whose work in antibody research holds promise for medical advancements. His patent on the fully human antibody targeting Connexin 26 exemplifies his commitment to innovation in healthcare. Through his contributions, he is paving the way for new treatments and solutions in the field of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile